ZYDUS WELLNESS LTD.
NSE : ZYDUSWELLBSE : 531335ISIN
CODE : INE768C01010Industry : Consumer FoodHouse
: Cadila
BSE1668.50-1.35 (-0.08 % )
PREV CLOSE (Rs.) 1669.85
OPEN PRICE (Rs.) 1649.30
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1436
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE1670.50 -0.5 (-0.03 % )
PREV CLOSE(Rs.) 1671.00
OPEN PRICE (Rs.) 1671.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 26504
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 01-Mar-2024 | Zydus Wellness informs about change in management | <div style="text-align: justify;">Pursuant to the provisions of Regulation 30 of the Listing Regulations read with clause 7 of Para A of Part A of Schedule III of the Listing Regulations, Zydus Wellness has informed the appointment of Siva M. Sivaramakrishnan as Vice President, Research & Development, forming part of Senior Management of the Company with effect from March 1, 2024. Requisite details as per Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are given in attached Annexure -‘1'.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 26-Feb-2024 | Zydus Wellness informs about disclosure | <div style="text-align: justify;">Zydus Wellness has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Zydus Family Trust & PACs.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 26-Feb-2024 | Reply To Clarification Sought On Increase In Volume Of Shares | Reply to clarification sought on increase in volume of shares |
| 24-Feb-2024 | Zydus Wellness informs about disclosure | <div style="text-align: justify;">Zydus Wellness has enclosed a disclosure in prescribed Form ‘C' under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, received from Zydus Family Trust, Promoter of the Company with respect to acquisition of 1,10,000 Equity Shares of Rs 10 each from the open market.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 22-Feb-2024 | Zydus Wellness informs about loss of share certificate | <div>Zydus Wellness has informed that it enclosed intimation of loss of share certificate under Regulation 39(3) of the SEBI (LODR) Regulations, 2015.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 29-Jan-2024 | Zydus Wellness submits board meeting intimation | <div style="text-align: justify;">Pursuant to the provisions of regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zydus Wellness has informed that the meeting of the Board of Directors of the Company will be held on Thursday, February 8, 2024 to consider, apart from other agenda items, approval of unaudited financial results for the quarter and nine months ended on December 31, 2023. The trading window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015, shall remain closed until Sunday, February 11, 2024 and shall open for trading on and from Monday, February 12, 2024 for all the Directors and Designated Persons.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 10-Nov-2023 | Zydus Wellness informs about transcript of conference call | <p style="text-align: justify;">Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zydus Wellness has informed that it attached transcript of the Company's Q2 FY2024 Earnings Conference call held at 4:00 pm (IST) on Monday, November 6, 2023.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 30-Oct-2023 | Zydus Wellness informs about analyst meet | <p style="text-align: justify;">Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Zydus Wellness has informed that the Analyst / Institutional Investors' Conference ‘Anand Rathi Annual Flagship Conference' in which the representatives of the Company will be participating is scheduled on November 8, 2023 on Mumbai.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.<br></p><div style="text-align: justify;"><br></div> |
| 09-Oct-2023 | Zydus Wellness informs about loss of share certificate | <div>Zydus Wellness has informed that it received information of loss of share certificate and request for issue of duplicate share certificate.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 22-Sep-2023 | Zydus Wellness informs about issue of duplicate share certificate | <div>Zydus Wellness has informed that it has received information of loss of share certificate and request for issue of duplicate share certificate.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
